88
Views
5
CrossRef citations to date
0
Altmetric
BRIEF REPORT

Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: A pilot post-mortem study

, , , , , , , , , & show all
Pages 677-681 | Received 16 Nov 2009, Accepted 11 Feb 2010, Published online: 12 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tanja Maria Michel, Abigail Jane Sheldrick, Sybille Camara, Edna Grünblatt, Frank Schneider & Peter Riederer. (2011) Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia. The World Journal of Biological Psychiatry 12:8, pages 588-597.
Read now

Articles from other publishers (4)

Miquel Martorell, Xavier Lucas, Pedro Alarcón-Zapata, Xavier Capó, Maria Magdalena Quetglas-Llabrés, Silvia Tejada & Antoni Sureda. (2021) Targeting Xanthine Oxidase by Natural Products as a Therapeutic Approach for Mental Disorders. Current Pharmaceutical Design 27:3, pages 367-382.
Crossref
Paulina Wigner, Piotr Czarny, Ewelina Synowiec, Micha� Bijak, Katarzyna Białek, Monika Talarowska, Piotr Galecki, Janusz Szemraj & Tomasz Sliwinski. (2020) Variation of genes involved in oxidative and nitrosative stresses in depression. European Psychiatry 48:1, pages 38-48.
Crossref
Li Hui, Mei Han, Xiang Dong Du, Bao Hua Zhang, Shu Chang He, Tian Nan Shao & Guang Zhong Yin. (2017) Serum ApoB levels in depressive patients: associated with cognitive deficits. Scientific Reports 7:1.
Crossref
Jasmin Bartl, Claus-Jürgen Scholz, Margareta Hinterberger, Susanne Jungwirth, Ildiko Wichart, Michael K Rainer, Susanne Kneitz, Walter Danielczyk, Karl H Tragl, Peter Fischer, Peter Riederer & Edna Grünblatt. (2011) Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene. BMC Medical Genetics 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.